Last updated: 12 February 2024 at 4:30pm EST

Susan Knight Net Worth




The estimated Net Worth of Susan E Knight is at least 2.27 百万$ dollars as of 5 February 2024. Ms. Knight owns over 3,932 units of Surmodics stock worth over 1,422,754$ and over the last 21 years she sold SRDX stock worth over 631,531$. In addition, she makes 219,000$ as Non-Executive Independent Chairman of the Board at Surmodics.

Ms. Knight SRDX stock SEC Form 4 insiders trading

Susan has made over 32 trades of the Surmodics stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 3,932 units of SRDX stock worth 94,171$ on 5 February 2024.

The largest trade she's ever made was exercising 25,000 units of Surmodics stock on 10 May 2007 worth over 313,500$. On average, Susan trades about 3,858 units every 102 days since 2003. As of 5 February 2024 she still owns at least 36,267 units of Surmodics stock.

You can see the complete history of Ms. Knight stock trades at the bottom of the page.





Susan Knight biography

Susan E. Knight serves as Non-Executive Independent Chairman of the Board of the Company. She has been a director of the Company since 2008. From 2001 until 2014, she served in a variety of senior leadership positions at MTS Systems Corporation (“MTS”), a leading global supplier of test systems and industrial position sensors. From 2011 to 2014, she served as Senior Vice President and Chief Financial Officer of MTS. From 2001 to 2011, she served as Vice President and Chief Financial Officer of MTS. Prior to her positions with MTS, from 1977 to 2001, Ms. Knight served in various executive and management positions with Honeywell Inc., last serving as the Chief Financial Officer of the global Home and Building Controls division. Since December 2017, she has served on the Children’s Minnesota Hospital Board Finance Committee, and Ms. Knight has been appointed to the Mairs & Power Funds Trust Board of Trustees, effective January 2018. Ms. Knight served on the board of the Greater Metropolitan Housing Corporation from 2000 to 2016, where she was the Chair of the Board from 2012 to 2015, and Chair of the Audit Committee from 2003 to 2012. Ms. Knight also served on the board of Plato Learning, Inc., from 2006 to 2010, where she served on the Audit Committee, including as Chair from 2009 to 2010, and on the Governance and Nominating and a Special Committee from 2009 to 2010.

What is the salary of Susan Knight?

As the Non-Executive Independent Chairman of the Board of Surmodics, the total compensation of Susan Knight at Surmodics is 219,000$. There are 12 executives at Surmodics getting paid more, with Gary Maharaj having the highest compensation of 2,343,630$.



How old is Susan Knight?

Susan Knight is 65, she's been the Non-Executive Independent Chairman of the Board of Surmodics since 2015. There are 2 older and 18 younger executives at Surmodics. The oldest executive at Surmodics, Inc. is David Dantzker, 76, who is the Independent Director.

What's Susan Knight's mailing address?

Susan's mailing address filed with the SEC is 9154 BRECKENRIDGE LANE, , EDEN PRAIRIE, MN, 55437.

Insiders trading at Surmodics

Over the last 21 years, insiders at Surmodics have traded over 26,204,565$ worth of Surmodics stock and bought 19,725 units worth 436,251$ . The most active insiders traders include Jeffrey C SmithGary R MaharajValue Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of 415,014$. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth 706,662$.



What does Surmodics do?

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.



Complete history of Ms. Knight stock trades at MTS Systems、Surmodics

インサイダー
取引
取引
合計金額
Susan E Knight
オプション行使 94,171$
5 Feb 2024
Susan E Knight
オプション行使 88,106$
28 Feb 2022
Susan E Knight
オプション行使 118,825$
26 Feb 2021
Susan E Knight
オプション行使 152,766$
28 Aug 2018
Susan E Knight
販売 437,580$
16 Aug 2018
Susan E Knight
オプション行使 141,980$
29 Mar 2018
Susan E Knight
販売 44,335$
15 Aug 2016
Susan E Knight
オプション行使 223,500$
1 Aug 2016
Susan E Knight
販売 52,076$
31 May 2016
Susan E Knight
販売 52,076$
31 May 2016
Susan E Knight
販売 22,733$
27 May 2016
Susan E Knight
販売 22,733$
27 May 2016
Susan E Knight
オプション行使 152,884$
16 May 2016
Susan E Knight
オプション行使 152,884$
16 May 2016
Susan E Knight
購入する 30,540$
8 May 2014
Susan E Knight
購入する 9,485$
9 Feb 2009
Susan E Knight
Vice President、CFO
オプション行使 963,427$
13 Aug 2014
Susan E Knight
Vice President、CFO
オプション行使 23,157$
12 Aug 2014
Susan E Knight
Vice President、CFO
オプション行使 245,531$
13 Aug 2013
Susan E Knight
Vice President、CFO
オプション行使 26,359$
9 Aug 2013
Susan E Knight
Vice President、CFO
オプション行使 402,537$
28 Aug 2012
Susan E Knight
Vice President、CFO
オプション行使 464,108$
10 Aug 2012
Susan E Knight
Vice President、CFO
オプション行使 373,082$
17 Feb 2011
Susan E Knight
Vice President、CFO
オプション行使 60,784$
15 Feb 2011
Susan E Knight
Vice President、CFO
オプション行使 388,073$
14 Feb 2011
Susan E Knight
Vice President、CFO
オプション行使 534,720$
1 Jun 2009
Susan E Knight
Vice President、CFO
オプション行使 180,697$
14 May 2008
Susan E Knight
Vice President、CFO
オプション行使 313,500$
10 May 2007
Susan E Knight
Vice President、CFO
オプション行使 113,497$
1 Feb 2007
Susan E Knight
Vice President、CFO
購入する 21,245$
22 Nov 2005
Susan E Knight
Vice President、CFO
オプション行使 109,000$
27 Jan 2005
Susan E Knight
Vice President、CFO
オプション行使 109,000$
22 Nov 2004


Surmodics executives and stock owners

Surmodics executives and other stock owners filed with the SEC include: